ISIS PHARMACEUTICALS INC
S-3/A, EX-23.1, 2000-08-25
PHARMACEUTICAL PREPARATIONS
Previous: ISIS PHARMACEUTICALS INC, S-3/A, 2000-08-25
Next: AES CORPORATION, 424B2, 2000-08-25



<PAGE>   1
                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in Amendment
No. 1 to the Registration Statement (Form S-3) and related Prospectus of Isis
Pharmaceuticals, Inc. for the registration of 4,000,000 shares of its common
stock and to the incorporation by reference therein of our report dated January
28, 2000, with respect to the financial statements of Isis Pharmaceuticals, Inc.
included in its Annual Report (Form 10-K) for the year ended December 31, 1999,
filed with the Securities and Exchange Commission.

                                        /s/ ERNST & YOUNG LLP
                                        ---------------------------
                                        ERNST & YOUNG LLP

San Diego, California
August 24, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission